Rybelsus (semaglutide) 14 mg is a daily oral GLP-1 receptor agonist used to improve blood sugar control in adults with type 2 diabetes, often reducing cardiovascular risks and aiding in weight management. It is the highest dose available after stepping up from 7 mg and must be taken on an empty stomach with a sip of water.
